ArticleBioactive materials2025

A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth.

Alessandra Caliendo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.